Overview
In this webinar, we’ll explore how Waters and MKI accelerate the development and quality control of safe, effective RNA therapeutics with a comprehensive suite of tools—including novel sample prep enzymes, high-purity reagents, application-specific standards, and streamlined informatics. These innovations enable routine, in-depth characterization of critical quality attributes such as 5’ capping efficiency, 3’ poly(A) tail heterogeneity, and oligonucleotide mapping.
We’ll showcase the waters_connect platform, simplifying automated MS1 data analysis with seamless integration with third-party tools. Special guest Matsubara-san from MKI will present the AQXeNA software, offering automated MS2-based oligonucleotide mapping for early-stage RNA product development.